X-16639224-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP3
The NM_175859.3(CTPS2):āc.1316A>Gā(p.His439Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00000166 in 1,202,575 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000089 ( 0 hom., 1 hem., cov: 22)
Exomes š: 9.2e-7 ( 0 hom. 1 hem. )
Consequence
CTPS2
NM_175859.3 missense
NM_175859.3 missense
Scores
5
5
7
Clinical Significance
Conservation
PhyloP100: 6.17
Genes affected
CTPS2 (HGNC:2520): (CTP synthase 2) The protein encoded by this gene catalyzes the formation of CTP from UTP with the concomitant deamination of glutamine to glutamate. This protein is the rate-limiting enzyme in the synthesis of cytosine nucleotides, which play an important role in various metabolic processes and provide the precursors necessary for the synthesis of RNA and DNA. Cancer cells that exhibit increased cell proliferation also exhibit an increased activity of this encoded protein. Thus, this protein is an attractive target for selective chemotherapy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.759
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTPS2 | NM_175859.3 | c.1316A>G | p.His439Arg | missense_variant | 14/19 | ENST00000359276.9 | NP_787055.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTPS2 | ENST00000359276.9 | c.1316A>G | p.His439Arg | missense_variant | 14/19 | 1 | NM_175859.3 | ENSP00000352222 | P1 | |
CTPS2 | ENST00000380241.7 | c.1316A>G | p.His439Arg | missense_variant | 14/19 | 1 | ENSP00000369590 | P1 | ||
CTPS2 | ENST00000443824.5 | c.1316A>G | p.His439Arg | missense_variant | 14/19 | 2 | ENSP00000401264 | P1 | ||
CTPS2 | ENST00000455276.1 | c.182A>G | p.His61Arg | missense_variant | 4/5 | 5 | ENSP00000400431 |
Frequencies
GnomAD3 genomes AF: 0.00000893 AC: 1AN: 111970Hom.: 0 Cov.: 22 AF XY: 0.0000293 AC XY: 1AN XY: 34110
GnomAD3 genomes
AF:
AC:
1
AN:
111970
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
34110
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 9.17e-7 AC: 1AN: 1090605Hom.: 0 Cov.: 28 AF XY: 0.00000281 AC XY: 1AN XY: 356207
GnomAD4 exome
AF:
AC:
1
AN:
1090605
Hom.:
Cov.:
28
AF XY:
AC XY:
1
AN XY:
356207
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000893 AC: 1AN: 111970Hom.: 0 Cov.: 22 AF XY: 0.0000293 AC XY: 1AN XY: 34110
GnomAD4 genome
AF:
AC:
1
AN:
111970
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
34110
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 06, 2024 | The c.1316A>G (p.H439R) alteration is located in exon 14 (coding exon 13) of the CTPS2 gene. This alteration results from a A to G substitution at nucleotide position 1316, causing the histidine (H) at amino acid position 439 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Pathogenic
D;D;D
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;.
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;L
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D
REVEL
Pathogenic
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
D;D;D
Vest4
MutPred
Gain of disorder (P = 0.0677);Gain of disorder (P = 0.0677);Gain of disorder (P = 0.0677);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at